Foley Catheter Market is Growing at CAGR of 5.9% Amid Rising Urinary Disorders and Technological Advancements

The global foley catheter market is projected to expand from a valuation of USD 4 billion in 2020 to USD 7.1 billion by 2031, reflecting a stable CAGR of 5.9% during the forecast period from 2021 to 2031. The increasing incidence of urological disorders and urinary retention, along with continual innovations aimed at enhancing patient comfort, are some of the major drivers accelerating demand for foley catheters across the healthcare industry.

Rising Burden of Urinary Disorders Fuels Market Growth

According to the American Academy of Family Physicians (AAFP), urinary retention affects 4.5 to 6.8 males per 1,000 men annually. These conditions often result from spinal cord injuries, dementia, multiple sclerosis, or as a side effect of certain medications. When such complications become unmanageable through non-invasive methods, healthcare professionals recommend the use of foley catheters for short- or medium-term periods.

Between 2016 and 2020, the foley catheter market grew at a CAGR of 5%, primarily due to the rising prevalence of urinary tract infections (UTIs). Moving forward, the incorporation of antibacterial coatings and improved materials is expected to further boost patient compliance and safety, driving sustained growth.

Browse for Full Report: https://www.factmr.com/report/4654/foley-catheters-market

Innovations Transforming Foley Catheter Industry

Numerous technological advancements are shaping the foley catheter market landscape. The development of antibacterial coatings, hydrogel-silicone linings, and non-latex alternatives has substantially reduced the risk of catheter-associated urinary tract infections (CAUTIs), thereby increasing product adoption. For instance, foley catheters made of silicone offer higher biocompatibility and lower encrustation risk compared to traditional latex catheters.

Moreover, increasing awareness about urinary incontinence, benign prostatic hyperplasia (BPH), and bladder obstructions has enhanced market penetration. The Centers for Disease Control and Prevention (CDC) estimates that 15-25% of hospitalized patients and 5-10% of nursing home residents require foley catheterization, pointing to a consistent demand from institutional care settings.

Challenges: Risks Associated with Catheterization

Despite the benefits, the foley catheter market faces certain restraints. Improper insertion or removal can cause friction against the urethral walls, resulting in pain, infection, or urethral strictures. Additionally, the availability of both invasive and non-invasive alternatives for managing temporary incontinence may reduce the long-term dependency on foley catheters, especially in outpatient or homecare settings.

Regional Insights: U.S., Asia, and Europe Drive Market Leadership

United States

The U.S. remains a leading market, expected to reach USD 726 million by 2031 with a CAGR of 5.8%. The country accounts for more than one-third of the global foley catheter revenue, thanks to a high prevalence of urological conditions, increased surgical interventions, and a rapidly aging population. Availability of advanced urinary management solutions and strong reimbursement frameworks also contribute to market expansion.

Asia

Asia is emerging as a high-potential market, with expected growth from USD 171.1 million in 2019 to USD 286 million by 2031, reflecting a CAGR of 6.8%. Countries like India and China are witnessing rising prevalence of UTIs and other urological conditions. In India, around 37% of both males and females suffer from culture-positive urinary infections, while in China, the figure is nearly 28% for both genders, underlining the strong demand for effective catheterization solutions.

Europe

Europe ranks as the second-largest market, projected to account for 40% of the global foley catheter demand. High rates of indwelling catheter use have led to significant healthcare costs, with WHO estimating direct costs of €2.01 billion annually for urinary infection-related hospitalization. As a result, many European healthcare providers are pushing for regular catheter replacements and more efficient catheter designs to reduce complications and associated costs.

Product Insights: Preference for 2-Way Latex and Silicone Catheters

2-Way Latex Catheters Dominate

2-way foley catheters, particularly those made of latex, continue to dominate the global market. These are preferred for their large balloon capacity, better sphincter control, and cost-effectiveness. Latex variants coated with silicone elastomer are widely used, accounting for nearly 90.4% of the market by 2031 and growing at a CAGR of 5.8%.

Silicone Catheters Gain Popularity

Silicone-based catheters are witnessing growing preference due to their extended usability, lower infection risks, and reduced friction. These are expected to register a robust CAGR of 7.2% through 2031, driven by increasing use in long-term catheterization and elderly care.

Want a Sample Before Buying? Download Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=4654

Competitive Landscape

Key players in the foley catheter market are prioritizing technological innovation, product diversification, and geographic expansion. Major companies include:

ConvaTec Inc. - Offers GentleCathTM catheters with polished eyelets and soft tips.
Romsons - Markets the Uro Cath 2-way latex catheter with silicone elastomer.
Coloplast Corp., Teleflex Incorporated, B. Braun Melsungen AG, and Cardinal Health - Offer a wide portfolio of coated and uncoated catheters.
Rusch EasyCath Catheters - Available in multiple sizes for different age groups and clinical settings.

These companies are also engaging in mergers, acquisitions, and distribution partnerships to enhance their global reach and product portfolio.

With an increasing elderly population, rising incidence of urinary disorders, and constant product innovations, the global foley catheter market is well-positioned for steady growth. The market's valuation is projected to rise from USD 4 billion in 2020 to USD 7.1 billion by 2031, growing at a CAGR of 5.9%. While challenges such as infection risks and the availability of alternative treatments persist, rising demand across hospitals, surgical centers, and long-term care facilities will ensure a resilient trajectory for the market.

Check out More Related Studies Published by Fact.MR Research:

Allyl Cyanide Market: https://www.factmr.com/report/3332/allyl-cyanide-market

Pediatric Chronic Rhinosinusitis Market: https://www.factmr.com/report/3346/pediatric-chronic-rhinosinusitis-market

Industrial Dehumidifiers Market: https://www.factmr.com/report/3351/industrial-dehumidifiers-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.